Key Insights

Highlights

Success Rate

77% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

7.3%

3 terminated out of 41 trials

Success Rate

76.9%

-9.6% vs benchmark

Late-Stage Pipeline

5%

2 trials in Phase 3/4

Results Transparency

0%

0 of 10 completed with results

Key Signals

77% success

Data Visualizations

Phase Distribution

24Total
Not Applicable (13)
P 1 (4)
P 2 (5)
P 3 (1)
P 4 (1)

Trial Status

Recruiting12
Unknown11
Completed10
Terminated3
Active Not Recruiting3
Withdrawn2

Trial Success Rate

76.9%

Benchmark: 86.5%

Based on 10 completed trials

Clinical Trials (41)

Showing 20 of 20 trials
NCT06486454Recruiting

Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)

NCT07466602RecruitingPrimary

cfDNA Methylation for Liver Cancer Recurrence Detection

NCT07437859Active Not RecruitingPrimary

Exploring the Application of 3D Bioprinting for Personalized Treatment in Primary Liver Cancer With Tumor Microenvironment

NCT05267080Active Not RecruitingPrimary

Registry on Percutaneous Electrochemotherapy

NCT07349576Not ApplicableCompletedPrimary

Precision Dietary Intervention Improves Postoperative Energy Intake, Nutritional Status, and Recovery in Patients Undergoing Hepatectomy for Liver Cancer: A Randomized Controlled Trial

NCT07145801Phase 2Recruiting

Y-90 Treatment Response Using Transarterial Radioembolization

NCT07101237Recruiting

An Exploratory Study on Developing an Integrated Approach Combining Multimodal Imaging and Multi-omics Characterization of Tumor Heterogeneity for Precision Diagnosis and Treatment Optimization in Liver Cancer.

NCT06914648Not ApplicableRecruitingPrimary

The Dragon PLC Trial (DRAGON-PLC)

NCT06342414Recruiting

An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer

NCT06905015Not ApplicableRecruiting

Stroke Volume Variation Versus Central Venous Pressure Guidance for Reducing Perioperative Blood Loss During Open Liver Resection

NCT06766643Phase 2RecruitingPrimary

Stereotactic Radiosurgery Versus Radiofrequency Ablation for Primary Liver Cancer

NCT01640522Not ApplicableCompleted

Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms

NCT06430983Recruiting

Recurrent Liver Cancer: Reconceptualization and Reevaluation

NCT06588569Not ApplicableActive Not RecruitingPrimary

Multi-mode Ablation and Molecular Imaging Multi-omics Study for Digestive-Origin Malignant Liver Tumors

NCT04806464Phase 1RecruitingPrimary

Clinical Study of VG161 in Subjects with Advanced Primary Liver Cancer

NCT05714124Recruiting

Liver Embolization Approaches for Tumor Management

NCT06325267RecruitingPrimary

Clinical Characteristics of Primary Liver Cancer

NCT05292443WithdrawnPrimary

Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated Primary Liver Cancer

NCT00906984Unknown

TheraSphere® for Treatment of Unresectable Hepatocellular Carcinoma

NCT05609448Not ApplicableUnknownPrimary

MRI-guided Holmium-166 Radioembolization

Scroll to load more

Research Network

Activity Timeline